Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-02-07
2011-11-22
Kosar, Andrew D (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S491000
Reexamination Certificate
active
08063094
ABSTRACT:
Heterocyclic compounds which are inhibitors of Mitrogen-Activated Protein Kinase-Activated Protein Kinase-2 (MAPKAP-K2) as described, in addition to their use in the treatment of cytokine mediated diseases.
REFERENCES:
patent: 3216898 (1965-11-01), Fellows
patent: 4428877 (1984-01-01), Szantay et al.
patent: 4839377 (1989-06-01), Bays et al.
patent: 6821966 (2004-11-01), Dugar et al.
patent: 6906067 (2005-06-01), Moriarty et al.
patent: 7169925 (2007-01-01), Merriman et al.
patent: 2006/0183906 (2006-08-01), Rodgers et al.
patent: 2006/0276496 (2006-12-01), Goldberg et al.
patent: 888.426 (1958-04-01), None
Bradham et al, p38 MAPK in Development and Cancer, Cell Cycle, 2006, vol. 5:8, p. 824-828.
Evgen'ev et al, Flow-Injection Determination of Indole Derivatives in Pharmaceutical Mixtures, Journal of Analytical Chemistry, 2006, vol. 6, No. 7, p. 694-701.
Golub et al, Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring, Science, 1999, vol. 286, p. 531-537.
King, Role of Inflammatory Cytokines in Diabetes and Its Complications, J. Periodontol, Jun. 2008, vol. 79, p. 1527-1534.
Medical News: Inflammatory Cytokines Linked to Alzheimers Disease, http://www.medpagetoday.com/Neurology/AlzheimersDisease/5796, accessed Apr. 26, 2011.
Moya et al, Synthesis of 7-fluoro- and 6,7-difluoroserotonin and 7-fluoro- and 6,7-difluoromelatonin, Journal of Fluorine Chemistry, 2006, vol. 127, p. 1256-1260.
Shioi et al, Proinflammatory Cytokine Inhibitor Prolongs Survival of Rats with Heart Failure Induced by Pressure Overload, Jpn Circ J, 2001, vol. 65, p. 584-585.
Targeted Cancer Therapies, http://www.cancer.gov/cancertopics/factsheet/therapy/targeted, accessed Jan. 12, 2011.
Zenvirt et al, Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents, Oncogene, 2010, vol. 29, p. 6149-6159.
Abeywardane Asitha
Andersen Denise
Morwick Tina Marie
Snow Roger John
Ward Yancey David
Boehringer Ingelheim International GmbH
Cheng Karen
Kosar Andrew D
Lazer Edward S.
Morris Michael P.
LandOfFree
Anti-cytokine heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-cytokine heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cytokine heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4277621